Secondary Logo

Journal Logo

Hypertension in 2014: Making sense of the guidelines

doi: 10.1097/01.NPR.0000450820.67133.81
CE Connection

For more than 136 additional continuing education articles related to advanced practice nursing topics, go to

Earn CE credit online: Go to and receive a certificate within minutes.

Back to Top | Article Outline

INSTRUCTIONS Hypertension in 2014: Making sense of the guidelines


  • To take the test online, go to our secure website at
  • On the print form, record your answers in the test answer section of the CE enrollment form on page 24. Each question has only one correct answer. You may make copies of these forms.
  • Complete the registration information and course evaluation. Mail the completed form and registration fee of $21.95 to: Lippincott Williams & Wilkins, CE Group, 74 Brick Blvd., Bldg. 4, Suite 206, Brick, NJ 08723. We will mail your certificate in 4 to 6 weeks. For faster service, include a fax number and we will fax your certificate within 2 business days of receiving your enrollment form.
  • You will receive your CE certificate of earned contact hours and an answer key to review your results.There is no minimum passing grade.
  • Registration deadline is June 30, 2016.
Back to Top | Article Outline


  • Send two or more tests in any nursing journal published by Lippincott Williams & Wilkins together and deduct $0.95 from the price of each test.
  • We also offer CE accounts for hospitals and other healthcare facilities on Call 1-800-787-8985 for details.
Back to Top | Article Outline


Lippincott Williams & Wilkins, publisher of The Nurse Practitioner journal, will award 2.0 contact hours for this continuing nursing education activity.

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 2.0 contact hours. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50–1223.

Your certificate is valid in all states.

The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.

Hypertension in 2014: Making sense of the guidelines

GENERAL PURPOSE: To review current hypertension guidelines. Learning Objectives: After reading the article and taking this test, you should be able to: 1. Identify the key differences between the 2013 ASH/ISH and JNC 8 hypertension publications. 2. Discuss hypertension management guidelines.

  1. In 2013, all of the following organizations published hypertension documentsexceptthe
    1. JNC.
    2. ASH and ISH.
    3. AHA, ACC, and CDC.
    4. NHLBI.
  2. The JNC 8 guidelines are based on
    1. expert opinion.
    2. AHA protocols.
    3. randomized clinical trials.
    4. longitudinal studies.
  3. JNC 8 researchers sought to answer whether health outcomes were improved by allexcept
    1. treating to specific BP goal.
    2. initiating therapy at specific BP thresholds.
    3. treating with specific medications.
    4. combining lifestyle changes with pharmacotherapy.
  4. A JNC 8 recommendation based on expert opinion or conflicting evidence is considered
    1. Grade A.
    2. Grade D.
    3. Grade E.
    4. ungraded.
  5. Initiating pharmacologic treatment in the general population 60 years and older at a SBP of 150 mm Hg or higher or DBP of 90 mm Hg or higher was recommended at Grade
    1. A.
    2. B.
    3. C.
    4. E.
  6. For people under age 60, JNC 8 guidelines focus on
    1. SBP.
    2. DBP.
    3. weight control.
    4. comorbidities.
  7. What do JNC 8 guidelines recommend for initial pharmacologic therapy in the general Black population?
    1. ACEIs
    2. ARBs
    3. beta-blockers
    4. thiazide-type diuretics or CCBs
  8. Initial or add-on therapy including ACEIs or ARBs is recommended by JNC 8 for
    1. all patients with diabetes.
    2. all patients with CKD.
    3. patients with kidney disease and diabetes.
    4. Black patients with kidney disease.
  9. Which condition is addressed in the ASH/ISH guidelines but not in JNC 8?
    1. diabetes
    2. stroke
    3. CVD
    4. resistant hypertension
  10. How do ASH/ISH guidelines define hypertension in adults over 80 years of age?
    1. BP of 140/90 mm Hg or higher
    2. DPB greater than 80 mm Hg
    3. SBP greater than 150 mm Hg
    4. SBP greater than 140 mm Hg
  11. What intervention is recommended by ASH/ISH guidelines for a patient with DBP between 80 and 89 mm Hg?
    1. none
    2. counseling about lifestyle modification
    3. pharmacotherapy
    4. assessment for comorbidities
  12. ASH/ISH guidelines classify SBP of 160 mm Hg or higher or DBP of 100 mm Hg or higher as
    1. prehypertension.
    2. Stage I hypertension.
    3. Stage II hypertension.
    4. Stage III hypertension.
  13. ACEIs or ARBs are recommended by ASH/ISH as Stage I initial therapy in
    1. non-Black patients less than 60 years.
    2. Black patients less than 60 years.
    3. non-Black patients over 60 years.
    4. Black patients over 60 years.
  14. For patients with resistant hypertension, ASH/ISH recommends adding
    1. hydrochlorothiazide.
    2. spironolactone.
    3. CCBs.
    4. peripheral adrenergic inhibitors.
  15. What drug treatment does JNC 8 recommend for Black patients with diabetes mellitus?
    1. ACEI
    2. ARB
    3. CCB
    4. potassium sparing diuretics
  16. The AHA/ACC/CDC Science Advisory discusses the importance of developing and disseminating
    1. published expert opinion.
    2. electronic medical records.
    3. accreditation standards.
    4. evidence-based algorithms.
  17. Which of the following isnota key AHA/ACC/CDC Advisory principle for creating hypertension algorithms?
    1. An appropriate patient version should be included.
    2. The algorithm should be stable, not requiring periodic updating.
    3. The cost of monitoring and treatment should be considered.
    4. The format should be compatible with electronic health records.
  18. AHA/ACC/CDC advises developers that algorithms shouldnotbe used to
    1. overtreat a vulnerable population.
    2. make specific treatment recommendations.
    3. discourage nonpharmacologic interventions.
    4. counter the healthcare provider's clinical judgment.


© 2014 Lippincott Williams & Wilkins